- F-16 Electric Control Box
- Antarctic Research Requiring U.S. Antarctic Program (USAP) Support for Fieldwork
- Antarctic Research Not Requiring U.S. Antarctic Program (USAP) Field Support
- Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Postdoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
- Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Predoctoral Research Training Grant for the Clinical and Translational Science Awards (CTSA) Program (T32 Clinical Trial Not Allowed)
- NHLBI Clinical Trial Pilot Studies (R34 Clinical Trial Optional)
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Not Allowed)
- NIH Exploratory/Developmental Research Project Grant (Parent R21 Clinical Trial Required)
- NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)
- NIH Research Project Grant (Parent R01 Clinical Trial Required)
- NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)
- Translational Efforts to Advance Gene-based Therapies for Ultra-Rare Neurological and Neuromuscular Disorders (U01 - Clinical Trial Optional)
- Annual Program Statement 2025
- Biomedical Advanced Research and Development Authority (BARDA) Broad Agency Announcement (BAA)
- Updated National Dislocated Worker Grant Program Guidance and Application Information
- D-START: Data Science Track Award for Research Transition (D/START) (R03-Clinical Trial Optional)
- Landslide Repairs in Morovis, Puerto Rico
- Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
- NIDCD Research Grants for Translating Basic Research into Clinical Practice (R01 Clinical Trial Optional)
- Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
- Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
- EPSCoR Research Infrastructure Improvement Program: EPSCoR Research Incubators for STEM Excellence (E-RISE)
- Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
- Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
- Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
- Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
- Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
- Logistics Technology Research (LTR) Program
- Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
- Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
- Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
- Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
- Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
- Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
- NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- Operational Test and Training Infrastructure (OTTI) Commercial Solutions Opening (CSO)
- Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
- Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
- Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Not Allowed)
- Security, Privacy, and Trust in Cyberspace (NSF SaTC)
- Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
- Accelerating the Pace of Substance Use Research Using Existing Data (R01 Clinical Trial Not Allowed)
- Accelerating the Pace of Substance Use Research Using Existing Data (R21 Clinical Trial Not Allowed)
- Calcasieu River and Pass, Bar Channel Hopper Dredge Contract No. 1-2025, Cameron Parish, Louisiana. Specification Nos. OM25125
- Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)
- NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R61/R33 Clinical Trial Required)
- One-Step Open BAA, US Army Combat Capabilities Development Command (DEVCOM) Indo-Pacific Fundamental Research Collaboration Opportunities
- Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
- Calcasieu River and Pass, Bar Channel Hopper Dredge Rental Contract No. 4-2025, Cameron Parish, Louisiana. Specification Nos. OM25128
- Calcasieu River and Pass, Bar Channel Hopper Dredge Contract No. 5-2025, Cameron Parish, Louisiana. Specification No. OM25129
- Mississippi River, Baton Rouge to the Gulf, Head of Passes, Hopper Dredge Disposal Area, Project #24-2, Plaquemines Parish, LA (ED 24-009)
- Calcasieu River and Pass, Bar Channel Hopper Dredge Contract No. 3-2025, Cameron Parish, Louisiana. Specification Nos. OM25127
- Calcasieu River and Pass, Bar Channel Hopper Dredge Rental Contract No. 2-2025, Cameron Parish, Louisiana. Specification Nos. OM25126
- Accelerating Solutions to Improve Access and Quality of Empirically-Supported Practices for Youth Mental Health (R01 Clinical Trial Optional)
- NIAID Career Transition Award (K22 Independent Clinical Trial Not Allowed)
- NSF Scholarships in Science, Technology, Engineering, and Mathematics (S-STEM)
- Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
- Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
- Commercial Solutions Opening (CSO) PEO-SDA
- Foundations of Trusted Systems
- Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
- Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
- NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
- NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
- NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
- NIDCR Behavioral and Social Intervention Clinical Trial Planning and Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
- Alcohol Health Services Research (R01 Clinical Trial Optional)
- Alcohol Health Services Research (R34 Clinical Trial Optional)
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R01 Clinical Trial Required)
- Alcohol Treatment, Pharmacotherapy, and Recovery Research (R34 Clinical Trial required)
- Confirmatory Efficacy Clinical Trials of Non-Pharmacological and Pharmacological Interventions for Mental Disorders (R01 Clinical Trial Required)
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R61/R33 Clinical Trial Required)
- Development of Psychosocial Therapeutic and Preventive Interventions for Mental Disorders (R33 Clinical Trial Required)
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R33- Clinical Trial Required)
- Early Stage Testing of Pharmacologic or Neuromodulatory Device-based Interventions for the Treatment of Mental Disorders (R61/R33 Clinical Trial Required)
- Effectiveness Trials to Test Mental Health System Interventions (R61/R33 Clinical Trial Required)
- First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based Interventions for Psychiatric Disorders (U01 Clinical Trial Required)
- Pilot Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 Clinical Trial Required)
- Full-Scale Hybrid Effectiveness-Implementation Trials for Mental Health Interventions (R01 - Clinical Trial Required)
- Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R01 Clinical Trial Required)
- Navigator Emergency Department Diversion Models for Non-Urgent Mental Health Concerns (R34 Clinical Trial Required)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R01 Clinical Trial Optional)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R34 Clinical Trial Optional)
- Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
- The Role of Work in Health Disparities in the U.S. (R01 Clinical Trials Optional)
- New Approaches for Measuring Brain Changes Across Longer Timespans (R21 Clinical Trial Optional)
- Catalyze: Enabling Technologies and Transformative Platforms for HLBS Research (R33 - Clinical Trials Not Allowed)
- Catalyze: Product Definition for Small Molecules, Biologics, and Combination Products - Preliminary Product/Lead Series Identification and Combination Product Prototype (R33 - Clinical Trial Not Allowed)
- Catalyze: Product Definition for Small Molecules, Biologics and Combination Products - Target Identification and Validation, and Preliminary Product/Lead Series Identification (R61/R33 Clinical Trials Not Allowed)
- Catalyze Product Definition Medical Device prototype design/testing and disease target identification and assay development (R61/R33 - Clinical Trial Not Allowed)
- Catalyze: Product Definition Medical Device Prototype Optimization (R33 - Clinical Trial Not Allowed)
- Mood and Psychosis Symptoms during the Menopause Transition (R01 Clinical Trial Optional)
- Mood and Psychosis Symptoms during the Menopause Transition (R21 Clinical Trial Optional)
- Occupational Safety and Health Training Project Grants (T03)
- Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Required)
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R01 Clinical Trial Optional)
- Utilizing Invasive Recording and Stimulating Opportunities in Humans to Advance Neural Circuitry Understanding of Mental Health Disorders (R21 Clinical Trial Optional)